Skip to main content
. 2008 May;3(3):822–828. doi: 10.2215/CJN.00030108

Figure 2.

Figure 2.

(A) Event-free survival stratified by calcineurin inhibitor use for major cardiac events. (B) Event-free survival stratified by calcineurin inhibitor use for all events (cardiac, stroke, peripheral vascular disease and congestive heart failure).